524
Participants
Start Date
August 2, 2017
Primary Completion Date
June 14, 2021
Study Completion Date
June 28, 2021
KAF156
KAF156 comes in 100 mg tablets for oral administration. KAF156 was administered in combination with LUM-SDF once daily (QD) for 1, 2 or 3 days at 200 mg, 400 mg or 800 mg doses.
Coartem
Coartem comes as 20/120 mg dispersible tablets or 80/480 mg tablets for oral administration. Coartem was administered twice daily for 3 days as active comparator.
Lumefantrine Solid Dispersion Formulation
LUM-SDF comes in 240 mg or 480 mg sachets for oral administration. LUM-SDF was administered in combination with KAF156 once daily (QD) for 1, 2 or 3 days at 480 mg or 960 mg doses.
Novartis Investigative Site, Siaya
Novartis Investigative Site, Tak
Novartis Investigative Site, Binh Phuoc Province
Novartis Investigative Site, Ranchi
Novartis Investigative Site, Nanoro
Novartis Investigative Site, Lambaréné
Novartis Investigative Site, Kombewa
Novartis Investigative Site, Sotouba
Novartis Investigative Site, Chokwé
Novartis Investigative Site, Masaka
Novartis Investigative Site, Tororo
Lead Sponsor
Medicines for Malaria Venture
OTHER
Novartis Pharmaceuticals
INDUSTRY